Departamento de Psiquiatría, Radioloxía, Saúde Pública, Enfermaría e Medicina
Departamento
University of Cambridge
Cambridge, Reino UnidoPublicacións en colaboración con investigadores/as de University of Cambridge (31)
2024
2023
-
Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement
Nature Reviews Endocrinology, Vol. 19, Núm. 12, pp. 722-740
-
Diminishing benefits of urban living for children and adolescents’ growth and development
Nature, Vol. 615, Núm. 7954, pp. 874-883
2022
-
Proceedings of the annual meeting of the European Consortium of Lipodystrophies (ECLip) Cambridge, UK, 7–8 April 2022
Annales d'Endocrinologie
-
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)
Nature
-
Stroke genetics informs drug discovery and risk prediction across ancestries
Nature, Vol. 611, Núm. 7934, pp. 115-123
2021
-
Consensus on diagnosis and management of Cushing's disease: a guideline update
The lancet. Diabetes & endocrinology, Vol. 9, Núm. 12, pp. 847-875
-
Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time?
Journal of the Endocrine Society, Vol. 5, Núm. 3
2020
-
A consensus on the diagnosis and treatment of acromegaly comorbidities: An update
Journal of Clinical Endocrinology and Metabolism, Vol. 105, Núm. 4, pp. E937-E946
-
European lipodystrophy registry: Background and structure
Orphanet Journal of Rare Diseases, Vol. 15, Núm. 1
-
Multidisciplinary management of acromegaly: A consensus
Reviews in Endocrine and Metabolic Disorders, Vol. 21, Núm. 4, pp. 667-678
2019
-
Association of alcohol consumption with allergic disease and asthma: a multi-centre Mendelian randomization analysis
Addiction, Vol. 114, Núm. 2, pp. 216-225
-
Data on hyper-activation of GPVI signalling in obese patients: Towards the identification of novel antiplatelet targets in obesity
Data in Brief
-
GPVI surface expression and signalling pathway activation are increased in platelets from obese patients: Elucidating potential anti-atherothrombotic targets in obesity
Atherosclerosis, Vol. 281, pp. 62-70
-
Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophy
Endocrine, Vol. 64, Núm. 3, pp. 500-511
-
Rising rural body-mass index is the main driver of the global obesity epidemic in adults
Nature
2018
-
Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: A pooled analysis of 1018 population-based measurement studies with 88.6 million participants
International Journal of Epidemiology, Vol. 47, Núm. 3, pp. 872-883i
-
Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy
Endocrine, Vol. 60, Núm. 3, pp. 479-489
2017
-
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants
The Lancet, Vol. 389, Núm. 10064, pp. 37-55
-
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults
The Lancet, Vol. 390, Núm. 10113, pp. 2627-2642